SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-033412
Filing Date
2020-02-12
Accepted
2020-02-12 17:14:36
Documents
6
Period of Report
2020-02-07
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d863520d8k.htm 8-K 31618
2 EX-1.1 d863520dex11.htm EX-1.1 210737
3 EX-3.1 d863520dex31.htm EX-3.1 82897
4 EX-4.1 d863520dex41.htm EX-4.1 95886
5 EX-99.1 d863520dex991.htm EX-99.1 10285
6 EX-99.2 d863520dex992.htm EX-99.2 10625
  Complete submission text file 0001193125-20-033412.txt   443458
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 20605388
SIC: 2834 Pharmaceutical Preparations